Regression of recurrent respiratory papillomatosis with celecoxib and erlotinib combination therapy

Chest

Volumn 136, Issue 3, 2009, Pages 924-926

  Limsukon, Atikun ^a,c   Susanto, Irawan ^b   Soo Hoo, Guy W ^a   Dubinett, Steven M ^a,b   Batra, Raj K ^a  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CIDOFOVIR; ERLOTINIB;

ACNE; ADULT; AIRWAY OBSTRUCTION; ARGON PLASMA COAGULATION; ARTICLE; BRONCHOSCOPY; CASE REPORT; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; HUMAN; MALE; OFF LABEL DRUG USE; PAPILLOMATOSIS; PATIENT MONITORING; PRIORITY JOURNAL; RECURRENT INFECTION; RESPIRATORY PAPILLOMATOSIS; TREATMENT RESPONSE;

EID: 70049107784     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-2639     Document Type: Article

References (11)

1. Steinberg BM, Topp WC, Schneider PS, et al. Laryngeal papillomavirus infection during clinical remission. N Engl J Med 1983; 308:1261-1264
2. Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis: a review. Laryngoscope 2008; 118:1236-1247
3. Bauman NM, Smith RJ. Recurrent respiratory papillomatosis. Pediatr Clin North Am 1996; 43:1385-1401
4. Chadha NK, James AL. Antiviral agents for the treatment of recurrent respiratory papillomatosis: a systematic review of the English-language literature. Otolaryngol Head Neck Surg 2007; 136:863-869
5. Vambutas A, Di Lorenzo TP, Steinberg BM. Laryngeal papilloma cells have high levels of epidermal growth factor receptor and respond to epidermal growth factor by a decrease in epithelial differentiation. Cancer Res 1993; 53:910-914 (Pubitemid 23077883)
6. Johnston D, Hall H, DiLorenzo TP, et al. Elevation of the epidermal growth factor receptor and dependent signaling in human papillomavirus-infected laryngeal papillomas. Cancer Res 1999; 59:968-974 (Pubitemid 29086756)
7. Zhang P, Steinberg BM. Overexpression of PTEN/MMAC1 and decreased activation of Akt in human papillomavirus-infected laryngeal papillomas. Cancer Res 2000; 60:1457-1462 (Pubitemid 30152021)
8. Wu R, Abramson AL, Shikowitz MJ, et al. Epidermal growth factor-induced cyclooxygenase-2 expression is mediated through phosphatidylinositol-3 kinase, not mitogen-activated protein/ extracellular signal-regulated kinase kinase, in recurrent respiratory papillomas. Clin Cancer Res 2005; 11:6155-6161 (Pubitemid 41262942)
9. Wu R, Coniglio SJ, Chan A, et al. Up-regulation of Rac1 by epidermal growth factor mediates COX-2 expression in recurrent respiratory papillomas. Mol Med 2007; 13:143-150 (Pubitemid 46944956)
10. Coffey RJ, Hawkey CJ, Damstrup L, et al. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci U S A 1997; 94:657-662 (Pubitemid 27053689)
11. Krysan K, Reckamp KL, Dalwadi H, et al. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res 2005; 65:6275-6281 (Pubitemid 40994413)